Home / Directory / The therapeutic potential of psilocybin in anorexia nervosa
Recruiting trial

The therapeutic potential of psilocybin in anorexia nervosa in young adults

Lund, Sweden · Ongoing, recruiting (EU CTIS)

Clinical trial authorised in the EU Clinical Trials Information System (CTIS). Condition: Anorexia Nervosa. Sponsor: Region Skane. Sites: Region Skane Skanes Universitetssjukhus (Lund). Estimated end: 2026-12-31.

Trial listings come from public registries. Taking part is up to the study team, who will check your eligibility. Recruitment status can change at any time, so check the registry record first.

Type
Recruiting trial
Location
Lund, Sweden
Status
Ongoing, recruiting (EU CTIS)
Registry
EU CTIS · 2024-515163-63-00
Sponsor
Region Skane
Condition
Anorexia Nervosa
Website
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-515163-63-00
Source
https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-515163-63-00
Last verified
19 November 2026

About this directory. Psyche Insights lists organisations for information only. A listing is not an endorsement, a recommendation or medical advice, and we do not take referral fees. We list only lawful, regulated services, registered clinical trials and professional training. We do not list retreats or anyone offering psychedelics outside the law. Psilocybin, MDMA, LSD and DMT are controlled drugs in the UK. Eligibility, availability and legal status differ by country and change often. Always check details with the provider or trial team, and talk to your GP or specialist before making any treatment decision. Paid placements are labelled “Featured · Paid placement” and never change our editorial descriptions. See our terms.

Corrections and removal. Spotted an error, or represent a listed organisation and want a listing corrected, updated or removed? Email [email protected] with the page link and the change needed. We aim to reply within 5 working days.

Follow access news each week

New trials, approvals and access routes, UK and Europe first.

Subscribe free →